Open AccessJournal Article
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
TLDR
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.Abstract:
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported The cultured cells show anchorage-independent growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice Culture of the transplanted tumor yielded a human cell line with characteristics identical to those used initially to produce the tumor PC-3 has a greatly reduced dependence upon serum for growth when compared to normal prostatic epithelial cells and does not respond to androgens, glucocorticoids, or epidermal or fibroblast gowth factors Karyotypic analysis by quinacrine banding revealed the cells to be completely aneuploid with a modal chromosome number in the hypotriploid range At least 10 distinctive marker chromosomes were identified The overall karyotype as well as the marker chromosomes are distinct from those of the HeLa cell Electron microscopic studies revealed many features common to neoplastic cells of epithelial origin including numerous microvilli, junctional complexes, abnormal nuclei and nucleoli, abnormal mitochondria, annulate lamellae, and lipoidal bodies Overall, the functional and morphologic characteristics of PC-3 are those of a poorly-differentiated adenocarcinoma These cells should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agentsread more
Citations
More filters
Journal Article
Characteristics of Human Diploid Fibroblasts Transformed in Vitro by Chemical Carcinogens
TL;DR: The AI phenotype appears to be an early marker for a carcinogen-induced change in human fibroblasts, but it is not systematically associated with the other phenotypic characteristics of transformation usually found concomitantly in rodent cell systems.
Journal ArticleDOI
Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents.
Rubing Wang,Chengsheng Chen,Xiaojie Zhang,Changde Zhang,Qiu Zhong,Guanglin Chen,Qiang Zhang,Shilong Zheng,Guangdi Wang,Qiao-Hong Chen +9 more
TL;DR: The structure-activity data acquired from the study validated (1,5-dihereroaryl-1,4-pentadien-3-ones as an excellent scaffold for in-depth development for clinical treatment of prostate and cervical cancers.
Journal ArticleDOI
Cholesterol as a Potential Target for Castration-Resistant Prostate Cancer
TL;DR: The findings to date suggest that cholesterol homeostasis is altered to support de novo androgen synthesis and appear to facilitate disease progression, and the implications of cholesterol dysregulation in CaP and particularly in the post-ADT castration-resistant state are summarized.
Journal ArticleDOI
Inhibition of apoptosis in prostate cancer cells by androgens is mediated through downregulation of c-Jun N-terminal kinase activation.
TL;DR: In this article, androgen deprivation induces the regression of prostate tumors mainly due to an increase in the apoptosis rate; however, the molecular mechanisms underlying the anti-apoptotic actions of androgens are not completely understood.
Journal ArticleDOI
Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells
Ariel E. Cariaga-Martínez,Pilar López-Ruiz,M. Paz Nombela-Blanco,Omar Motiño,Ana González-Corpas,Javier Rodríguez-Ubreva,Maria V.T. Lobo,M. Alicia Cortés,B. Colás +8 more
TL;DR: The data show that AKT1 and AKT2 have non-redundant roles in the regulation of PC-3 cell proliferation and migration and may help design new targeted strategies for inhibiting AKT isoforms in prostate cancer.